Malonyl-CoA, a key signaling molecule in mammalian cells
- PMID: 18598135
- DOI: 10.1146/annurev.nutr.28.061807.155434
Malonyl-CoA, a key signaling molecule in mammalian cells
Abstract
Malonyl-CoA can be formed within the mitochondria, peroxisomes, and cytosol of mammalian cells. Besides being an intermediate in the pathways of de novo fatty acid biosynthesis and fatty acid elongation, malonyl-CoA has an important signaling function through its allosteric inhibition of carnitine palmitoyltransferase 1, the enzyme that normally exerts flux control over mitochondrial beta-oxidation. Malonyl-CoA is rapidly turned over in mammalian cells, and the activities of acetyl-CoA carboxylase and malonyl-CoA decarboxylase are important determinants of its cytosolic concentration. It is now recognized that malonyl-CoA participates in a diverse range of physiological or pathological responses and systems. These include the ketogenic response of the liver to fasting and diabetes, carbohydrate versus fat fuel selection in muscle tissues, metabolic changes in muscle during contracture, alterations in fatty acid metabolism during cardiac ischemia and postischemic reperfusion, stimulation of B cell insulin secretion by glucose, and the hypothalamic control of appetite.
Similar articles
-
Regulation of food intake and energy expenditure by hypothalamic malonyl-CoA.Int J Obes (Lond). 2008 Sep;32 Suppl 4:S49-54. doi: 10.1038/ijo.2008.123. Int J Obes (Lond). 2008. PMID: 18719599 Review.
-
Expression of genes regulating malonyl-CoA in human skeletal muscle.J Cell Biochem. 2006 Oct 15;99(3):860-7. doi: 10.1002/jcb.20944. J Cell Biochem. 2006. PMID: 16721829
-
Malonyl CoA control of fatty acid oxidation in the newborn heart in response to increased fatty acid supply.Can J Physiol Pharmacol. 2006 Nov;84(11):1215-22. doi: 10.1139/y06-062. Can J Physiol Pharmacol. 2006. PMID: 17218986
-
Role of malonyl-CoA in heart disease and the hypothalamic control of obesity.Cardiovasc Res. 2007 Jan 15;73(2):278-87. doi: 10.1016/j.cardiores.2006.10.008. Epub 2006 Oct 20. Cardiovasc Res. 2007. PMID: 17126822 Review.
-
Differential carnitine/acylcarnitine translocase expression defines distinct metabolic signatures in skeletal muscle cells.J Cell Physiol. 2005 May;203(2):439-46. doi: 10.1002/jcp.20239. J Cell Physiol. 2005. PMID: 15515015
Cited by
-
Altered Metabolome of Lipids and Amino Acids Species: A Source of Early Signature Biomarkers of T2DM.J Clin Med. 2020 Jul 16;9(7):2257. doi: 10.3390/jcm9072257. J Clin Med. 2020. PMID: 32708684 Free PMC article. Review.
-
AMPK: Regulation of Metabolic Dynamics in the Context of Autophagy.Int J Mol Sci. 2018 Nov 29;19(12):3812. doi: 10.3390/ijms19123812. Int J Mol Sci. 2018. PMID: 30501132 Free PMC article. Review.
-
ACC inhibitor alone or co-administered with a DGAT2 inhibitor in patients with non-alcoholic fatty liver disease: two parallel, placebo-controlled, randomized phase 2a trials.Nat Med. 2021 Oct;27(10):1836-1848. doi: 10.1038/s41591-021-01489-1. Epub 2021 Oct 11. Nat Med. 2021. PMID: 34635855 Clinical Trial.
-
Fatty acid regulation of hepatic lipid metabolism.Curr Opin Clin Nutr Metab Care. 2011 Mar;14(2):115-20. doi: 10.1097/MCO.0b013e328342991c. Curr Opin Clin Nutr Metab Care. 2011. PMID: 21178610 Free PMC article. Review.
-
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Liver-Targeting Acetyl-CoA Carboxylase Inhibitor (PF-05221304): A Three-Part Randomized Phase 1 Study.Clin Pharmacol Drug Dev. 2020 May;9(4):514-526. doi: 10.1002/cpdd.782. Epub 2020 Feb 17. Clin Pharmacol Drug Dev. 2020. PMID: 32065514 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical